CHI ADVISORS LLC

Company

Corvus Pharmaceuticals, Inc.

Filed

February 13, 2023

Accession Number

0001085146-23-001070

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →